Mesoestetic, one of the world’s leading pharmaceutical manufacturers in the field of dermatology, cosmetic medicine and aesthetic medicine – celebrating its 30th anniversary this year – has received the Entrepreneurial Excellence 2014 award from leading Spanish business publication Dirigentes magazine in the category of R&D+i.
Each year Dirigentes recognises world-class companies for their outstanding business practices.
‘At mesoestetic, research is the driving force of innovation’, said Joan Carles Font, CEO and founder of mesoestetic Pharma Group, on receiving the award. ‘That is why we develop the majority of our large laboratory projects on-site, right at home.’
In its facilities located near Barcelona, mesoestetic Pharma Group has three production lines as well as a Biotechnology Unit and Medical Monitoring and Follow-up Unit. These two units enable the laboratory to take on the entire production cycle of products and perform in vitro and in vivo studies to design treatments with proven efficacy.
Implemented in late 2012, the Biotechnology Unit performs tests in cell cultures using techniques in molecular biology to find new active ingredients and combinations of ingredients of greater efficacy. ‘The two main lines of research of the Biotechnology Unit are ageing and depigmentation’, explains Joan Carles Font.
‘Our daily commitment is to use innovation to develop and perfect treatments in aesthetic medicine and cosmetics that offer the highest quality and efficacy.’
In addition to the work carried out internally, the laboratory’s Biotechnology Unit collaborates with research centres, universities and scientific groups in order to constantly position itself at the forefront of the advances in the field of cosmetic science.
Innovation is one of the fundamental pillars of mesoestetic Pharma Group. As evidence of this strategic commitment, the laboratory invests 40 percent of its profits in research and development every year.
Recently, the company spent 23 million Euros on building new headquarters equipped with the latest technology. The company is currently among the leading pharmaceutical laboratories in Europe.
In Spain, mesoestetic Pharma Group is one of the few pharmaceutical laboratories qualified to manufacture medical products for intradermal administration aimed at performing mesotherapy treatments for aesthetic purposes.
The brand is sold in more than 80 countries. It is a leader in anti-ageing therapies and depigmenting treatments.
Thanks to its effective products and almost 30 years’ experience, doctors, aesthetic professionals and users around the world, including Madonna, Beyonc and Jennifer Aniston, rely on mesoestetic.
www.advancedcosmeceuticals.com.au